GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » hVIVO PLC (DUB:HVO) » Definitions » Ending Cash Position

hVIVO (DUB:HVO) Ending Cash Position : €42.92 Mil (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is hVIVO Ending Cash Position?

hVIVO's Ending Cash Position for the quarter that ended in Dec. 2023 was €42.92 Mil.

hVIVO's quarterly Ending Cash Position increased from Dec. 2022 (€32.71 Mil) to Jun. 2023 (€36.53 Mil) and increased from Jun. 2023 (€36.53 Mil) to Dec. 2023 (€42.92 Mil).

hVIVO's annual Ending Cash Position increased from Dec. 2021 (€18.47 Mil) to Dec. 2022 (€32.71 Mil) and increased from Dec. 2022 (€32.71 Mil) to Dec. 2023 (€42.92 Mil).

hVIVO Ending Cash Position Historical Data

The historical data trend for hVIVO's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

hVIVO Ending Cash Position Chart

hVIVO Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.22 21.22 18.47 32.71 42.92

hVIVO Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.47 18.56 32.71 36.53 42.92

hVIVO Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

hVIVO's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=33.017+9.9
=42.92

hVIVO's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=36.385+6.532
=42.92

hVIVO Ending Cash Position Related Terms

Thank you for viewing the detailed overview of hVIVO's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

hVIVO (DUB:HVO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » hVIVO PLC (DUB:HVO) » Definitions » Ending Cash Position
Comparable Companies
LSE:ARIX LSE:SCLP LSE:FUM LSE:REDX LSE:FARN LSE:OBD LSE:BVXP LSE:4BB LSE:ETX LSE:AREC OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
ORPH:UK HVO:UK CRO:Germany
Address
42, New Road, Queen Mary Bioenterprises Innovation Centre, London, GBR, E1 2AX
Website
https://www.hvivo.com
hVIVO PLC is a European-focused, rare, and orphan drug consulting services platform. The principal activity of the Group is that of a rapidly growing specialist CRO pharmaceutical services company, which involves the testing of vaccines and antivirals using human-challenge clinical trials. The group is also engaged in Venn Life Sciences' Clinical Research Division, providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations.

hVIVO (DUB:HVO) Headlines

No Headlines